Literature DB >> 3102024

In vitro bone resorption activity produced by a hypercalcemic adenocarcinoma tumor line (CAC-8) in nude mice.

T J Rosol, C C Capen, C Minkin.   

Abstract

Tumor extracts and conditioned tissue culture media from a canine adenocarcinoma tumor line (CAC-8) propagated in nude mice significantly increased in vitro bone resorption in neonatal mouse calvaria as measured by release of previously incorporated 45Ca. In vitro bone resorption activity was induced in a dose-dependent manner, was not suppressible by indomethacin, and was heat- and acid-stable. Gel exclusion chromatography demonstrated peak bone resorbing activity at a relative molecular mass of approximately 28,000. The parathyroid hormone (PTH) antagonist (8,18norleucine, 34tyrosine) bovine PTH (3-34) amide did not inhibit CAC 8-stimulated or (1-34) bPTH-induced bone resorption. There was an increased number of tartrate-resistant, acid phosphatase-positive cells in calvariae exposed to CAC-8 extract. Ultrastructural evaluation of calvaria revealed hypertrophy and maturation of osteoclasts in calvaria exposed to CAC-8 extract. The maturation effects included close contact to bone surfaces and the presence of clear zones and ruffled borders in osteoclasts. Similar structures were observed infrequently in osteoclasts of control calvaria. These data demonstrate that the tumor line (CAC-8) contained activity capable of stimulating in vitro bone resorption by increasing osteoclast numbers and the activity of existing osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102024     DOI: 10.1007/bf02555201

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  20 in total

1.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

2.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis.

Authors:  S H Schelling; H J Wolfe; A H Tashjian
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

4.  A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.

Authors:  K H Lau; M Y Lee; T A Linkhart; S Mohan; J Vermeiden; C C Liu; D J Baylink
Journal:  Biochim Biophys Acta       Date:  1985-05-29

5.  Humoral hypercalcemia of malignancy in nude mouse model of a canine adenocarcinoma derived from apocrine glands of the anal sac. Biochemical, histomorphometric, and ultrastructural studies.

Authors:  T J Rosol; C C Capen; S E Weisbrode; R L Horst
Journal:  Lab Invest       Date:  1986-06       Impact factor: 5.662

6.  Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2, and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats.

Authors:  M E Holtrop; L G Raisz
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

7.  Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy.

Authors:  K J Ibbotson; S M D'Souza; K W Ng; C K Osborne; M Niall; T J Martin; G R Mundy
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

8.  Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.

Authors:  C Minkin; R S Fredericks; S Pokress; R K Rude; C F Sharp; M Tong; F R Singer
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.

Authors:  A H Tashjian; E F Voelkel; M Lazzaro; F R Singer; A B Roberts; R Derynck; M E Winkler; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.

Authors:  S M D'Souza; K J Ibbotson; G R Mundy
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more
  1 in total

1.  Adenylate cyclase-stimulating, bone-resorbing and B TGF-like activities in canine apocrine cell adenocarcinoma of the anal sac.

Authors:  E C Weir; M Centrella; R E Matus; M L Brooks; T Wu; K L Insogna
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.